Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Topiramate therapy for paroxysmal kinesigenic choreoathetosis.

Identifieur interne : 001060 ( Ncbi/Curation ); précédent : 001059; suivant : 001061

Topiramate therapy for paroxysmal kinesigenic choreoathetosis.

Auteurs : Yuan-Gui Huang [République populaire de Chine] ; Yun-Chun Chen ; Fang Du ; Rui Li ; Ge-Lin Xu ; Wen Jiang ; Jing Huang

Source :

RBID : pubmed:15390133

English descriptors

Abstract

We observed the clinical efficacy of topiramate for paroxysmal kinesigenic choreoathetosis (PKC). Topiramate was administered as a monotherapy with titrated dosages to 8 patients with PKC. Target daily dose of topiramate was 100 to 200 mg; the follow-up period ranged from 8 months to 2 years. All of the patients became attack-free, and side effects were mild. The results show that topiramate is effective as a monotherapy for treating patients with PKC. The response to topiramate indicates that the disease may be caused by an ion channel defect.

DOI: 10.1002/mds.20283
PubMed: 15390133

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:15390133

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Topiramate therapy for paroxysmal kinesigenic choreoathetosis.</title>
<author>
<name sortKey="Huang, Yuan Gui" sort="Huang, Yuan Gui" uniqKey="Huang Y" first="Yuan-Gui" last="Huang">Yuan-Gui Huang</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Shaanxi, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Shaanxi</wicri:regionArea>
<wicri:noRegion>Shaanxi</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chen, Yun Chun" sort="Chen, Yun Chun" uniqKey="Chen Y" first="Yun-Chun" last="Chen">Yun-Chun Chen</name>
</author>
<author>
<name sortKey="Du, Fang" sort="Du, Fang" uniqKey="Du F" first="Fang" last="Du">Fang Du</name>
</author>
<author>
<name sortKey="Li, Rui" sort="Li, Rui" uniqKey="Li R" first="Rui" last="Li">Rui Li</name>
</author>
<author>
<name sortKey="Xu, Ge Lin" sort="Xu, Ge Lin" uniqKey="Xu G" first="Ge-Lin" last="Xu">Ge-Lin Xu</name>
</author>
<author>
<name sortKey="Jiang, Wen" sort="Jiang, Wen" uniqKey="Jiang W" first="Wen" last="Jiang">Wen Jiang</name>
</author>
<author>
<name sortKey="Huang, Jing" sort="Huang, Jing" uniqKey="Huang J" first="Jing" last="Huang">Jing Huang</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15390133</idno>
<idno type="pmid">15390133</idno>
<idno type="doi">10.1002/mds.20283</idno>
<idno type="wicri:Area/PubMed/Corpus">003228</idno>
<idno type="wicri:Area/PubMed/Curation">003228</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F31</idno>
<idno type="wicri:Area/Ncbi/Merge">001060</idno>
<idno type="wicri:Area/Ncbi/Curation">001060</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Topiramate therapy for paroxysmal kinesigenic choreoathetosis.</title>
<author>
<name sortKey="Huang, Yuan Gui" sort="Huang, Yuan Gui" uniqKey="Huang Y" first="Yuan-Gui" last="Huang">Yuan-Gui Huang</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Shaanxi, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>The Department of Neurology, Xijing Hospital, the Fourth Military Medical University, Shaanxi</wicri:regionArea>
<wicri:noRegion>Shaanxi</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chen, Yun Chun" sort="Chen, Yun Chun" uniqKey="Chen Y" first="Yun-Chun" last="Chen">Yun-Chun Chen</name>
</author>
<author>
<name sortKey="Du, Fang" sort="Du, Fang" uniqKey="Du F" first="Fang" last="Du">Fang Du</name>
</author>
<author>
<name sortKey="Li, Rui" sort="Li, Rui" uniqKey="Li R" first="Rui" last="Li">Rui Li</name>
</author>
<author>
<name sortKey="Xu, Ge Lin" sort="Xu, Ge Lin" uniqKey="Xu G" first="Ge-Lin" last="Xu">Ge-Lin Xu</name>
</author>
<author>
<name sortKey="Jiang, Wen" sort="Jiang, Wen" uniqKey="Jiang W" first="Wen" last="Jiang">Wen Jiang</name>
</author>
<author>
<name sortKey="Huang, Jing" sort="Huang, Jing" uniqKey="Huang J" first="Jing" last="Huang">Jing Huang</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Anticonvulsants (therapeutic use)</term>
<term>Athetosis (complications)</term>
<term>Athetosis (drug therapy)</term>
<term>Child</term>
<term>Chorea (complications)</term>
<term>Chorea (drug therapy)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Fructose (analogs & derivatives)</term>
<term>Fructose (therapeutic use)</term>
<term>Humans</term>
<term>Male</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Fructose</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anticonvulsants</term>
<term>Fructose</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Athetosis</term>
<term>Chorea</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Athetosis</term>
<term>Chorea</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We observed the clinical efficacy of topiramate for paroxysmal kinesigenic choreoathetosis (PKC). Topiramate was administered as a monotherapy with titrated dosages to 8 patients with PKC. Target daily dose of topiramate was 100 to 200 mg; the follow-up period ranged from 8 months to 2 years. All of the patients became attack-free, and side effects were mild. The results show that topiramate is effective as a monotherapy for treating patients with PKC. The response to topiramate indicates that the disease may be caused by an ion channel defect.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001060 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001060 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:15390133
   |texte=   Topiramate therapy for paroxysmal kinesigenic choreoathetosis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:15390133" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024